Home Consumer Millions In The U.S. Take This Drug. Tariffs Might Complicate Their Care

Millions In The U.S. Take This Drug. Tariffs Might Complicate Their Care

Heparin comes in bags for intravenous drip and vials for injection.. (Photos by Micah E. Wood/For The Washington Post)

BALTIMORE — Thousands of miles from a manufacturing plant in China, where the key active ingredient in heparin is sourced, Wanda Crowell receives a daily infusion of the drug in her bed at Johns Hopkins Hospital.

Doctors give Crowell the inexpensive, essential anticoagulant every day, to prevent life-threatening blood clots from forming in her central line, a plastic tube inserted in her chest that delivers the nutrients she needs to live. A two-time cancer survivor, the 66-year-old has not been able to eat solid food since 2021. She also needs heparin to treat a history of blood clots.

For Crowell, there is no suitable alternative. While other patients may have options, she cannot take oral medications.

“If Wanda’s line is clotted off and we can’t get another line in, she would not get her nutrition,” said Peggy Kraus, a pharmacist on Crowell’s care team. “The drug is essential for her survival.”

Faith Based Events

The main focus of President Donald Trump’s on-again, off-again tariff campaign has been high-profile industries such as steel, automobiles and consumer electronics. But on Tuesday, Trump warned that another target will soon be the wide variety of medications whose active pharmaceutical ingredients are largely made in China and India.

No one knows how big a tariff is coming or what its effect on generic drugs like heparin may be. But along the supply chain that ends at Crowell’s bedside, many are worried.

Continue reading


Disclaimer

Artificial Intelligence Disclosure & Legal Disclaimer

AI Content Policy.

To provide our readers with timely and comprehensive coverage, South Florida Reporter uses artificial intelligence (AI) to assist in producing certain articles and visual content.

Articles: AI may be used to assist in research, structural drafting, or data analysis. All AI-assisted text is reviewed and edited by our team to ensure accuracy and adherence to our editorial standards.

Images: Any imagery generated or significantly altered by AI is clearly marked with a disclaimer or watermark to distinguish it from traditional photography or editorial illustrations.

General Disclaimer

The information contained in South Florida Reporter is for general information purposes only.

South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service. In no event shall South Florida Reporter be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of the Service or the contents of the Service.

The Company reserves the right to make additions, deletions, or modifications to the contents of the Service at any time without prior notice. The Company does not warrant that the Service is free of viruses or other harmful components.



South Florida Reporter

Join Our Newsletter

Sign up to receive news right to your inbox every day

Close